经尿道膀胱肿瘤电切术后辅助膀胱热灌注化疗的应用进展  

Application progress of bladder hyperthermic perfusion chemotherapy after transurethral resection of bladder tumor

作　　者：王俞[1] 李煜罡[1] 

机构地区：[1]南方医科大学中西医结合医院外二科,广州510315

出　　处：《临床肿瘤学杂志》2016年第6期560-563,共4页Chinese Clinical Oncology

基　　金：广东省科技计划项目(20140211);南方医科大学中西医结合医院院长基金资助项目(1201401001)

摘　　要：膀胱癌是泌尿系统最常见的恶性肿瘤,占我国泌尿生殖系肿瘤发病率的第1位,膀胱癌的生物学特点是术后易复发。近年来,在给膀胱癌患者行经尿道膀胱肿瘤电切术后再辅以膀胱热灌注化疗,能有效降低术后复发率,临床疗效显著。本文就经尿道膀胱肿瘤电切术后辅助膀胱热灌注化疗治疗膀胱癌的临床应用进展作一简要综述。Bladder cancer is the most common malignant tumor of urinary system,which has taken the first place in the incidence of urinary reproductive system tumor in our country. The method of bladder hyperthermic perfusion chemotherapy was proved to be a useful and effective method in the prevention of superficial bladder cancer recurrence of patients with superficial bladder cancer after transurethral resection. This article will focus on the clinical applications of bladder hyperthermic perfusion chemotherapy in the bladder cancer.

关 键 词：膀胱癌 膀胱热灌注化疗 经尿道膀胱肿瘤切除术 

分 类 号：R739.5[医药卫生—肿瘤]